Skip to main navigation
Skip to search
Skip to main content
VTT's Research Information Portal Home
Home
Profiles
Research output
Projects
Datasets
Research units
Research Infrastructures
Activities
Prizes
Press/Media
Impacts
Search by expertise, name or affiliation
BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition
Pia Vahteristo
*
, Kirsi Syrjäkoski
, Tuomas Heikkinen
, Hannaleena Eerola
, Kristiina Aittomäki
, Karl von Smitten
, Kaija Holli
, Carl Blomqvist
, Olli-Pekka Kallioniemi
, Heli Nevanlinna
*
Corresponding author for this work
VTT Technical Research Centre of Finland
Helsinki University Hospital
University of Helsinki
Tampere University
Tampere University Hospital (TAYS)
Uppsala University Hospital
VTT (former employee or external)
University of Turku
Research output
:
Contribution to journal
›
Article
›
Scientific
›
peer-review
37
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Breast Cancer Predisposition
100%
RING Domain
100%
Breast Cancer Susceptibility Gene 1 (BRCA1)
100%
Breast Cancer Patients
80%
Healthy Controls
60%
Breast Cancer Risk
60%
Breast Cancer
40%
Familial Breast Cancer
40%
Somatic mutation
20%
Statistical Significance
20%
Protein Drug
20%
Ovarian Cancer
20%
Tumor Suppressor
20%
Patient-controlled
20%
Genetic Variants
20%
Breast Cancer Susceptibility
20%
Germline mutation
20%
Uterine Cancer
20%
Deleterious mutations
20%
Missense
20%
Endometrial Cancer
20%
Germline Alterations
20%
Mutation Screening
20%
Germline Variants
20%
INIS
cancer
100%
breasts
100%
rings
100%
patients
41%
control
25%
risks
25%
mutations
25%
screening
16%
proteins
8%
tumors
8%
genes
8%
genetics
8%
ovaries
8%
Biochemistry, Genetics and Molecular Biology
BRCA1
100%
RING Finger Domain
100%
Germline
40%
Germ Cell
40%
Genetic Divergence
20%
Tumor Suppressor Protein
20%
Somatic Mutation
20%
Allele
20%
Germline Mutation
20%
Missense
20%